Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terhi Vihervaara

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Journal of Molecular Biology|February 1, 2008
dFOXO regulates transcription of a Drosophila acid lipaseTerhi Vihervaara, Oscar Puig
Drug Discovery Today|September 24, 2013
Lipidomics in drug discoveryTerhi Vihervaara, Matti Suoniemi, Reijo Laaksonen
Biochimie|May 22, 2012
Modification of the lipidome in RAW264.7 macrophage subjected to stable silencing of oxysterol-binding proteinsTerhi Vihervaara, Reijo Käkelä, Gerhard Liebisch, et al.
Experimental Cell Research|June 12, 2012
Silencing of OSBP-related protein 8 (ORP8) modifies the macrophage transcriptome, nucleoporin p62 distribution, and migration capacityOlivier Béaslas, Terhi Vihervaara, Jiwei Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 24, 2023
Combined use of the ELF test and CLivD score improves prediction of liver-related outcomes in the general populationFredrik Åberg, Kustaa Saarinen, Antti Jula, et al.
Cellular and Molecular Life Sciences : CMLS|August 7, 2010
Sterol binding by OSBP-related protein 1L regulates late endosome motility and functionTerhi Vihervaara, Riikka-Liisa Uronen, Gerd Wohlfahrt, et al.
Chemistry and Physics of Lipids|March 23, 2011
Cytoplasmic oxysterol-binding proteins: sterol sensors or transporters?Terhi Vihervaara, Maurice Jansen, Riikka-Liisa Uronen, et al.
Scandinavian Journal of Gastroenterology|February 11, 2025
The use of ELF in predicting liver fibrosis prevalence and fibrosis progression in the general populationKustaa Saarinen, Martti Färkkilä, Antti Jula, et al.
JHEP Reports : Innovation in Hepatology|June 19, 2023
Enhanced liver Fibrosis® test predicts liver-related outcomes in the general populationKustaa Saarinen, Martti Färkkilä, Antti Jula, et al.
JHEP Reports : Innovation in Hepatology|October 18, 2023
Erratum to: "Enhanced Liver Fibrosis® test predicts liver-related outcomes in the general population" (JHEP Reports 2023; 5: 100765)Kustaa Saarinen, Martti Färkkilä, Antti Jula, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Journal of Molecular Biology|February 1, 2008
dFOXO regulates transcription of a Drosophila acid lipaseTerhi Vihervaara, Oscar Puig
Drug Discovery Today|September 24, 2013
Lipidomics in drug discoveryTerhi Vihervaara, Matti Suoniemi, Reijo Laaksonen
Biochimie|May 22, 2012
Modification of the lipidome in RAW264.7 macrophage subjected to stable silencing of oxysterol-binding proteinsTerhi Vihervaara, Reijo Käkelä, Gerhard Liebisch, et al.
Experimental Cell Research|June 12, 2012
Silencing of OSBP-related protein 8 (ORP8) modifies the macrophage transcriptome, nucleoporin p62 distribution, and migration capacityOlivier Béaslas, Terhi Vihervaara, Jiwei Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 24, 2023
Combined use of the ELF test and CLivD score improves prediction of liver-related outcomes in the general populationFredrik Åberg, Kustaa Saarinen, Antti Jula, et al.
Cellular and Molecular Life Sciences : CMLS|August 7, 2010
Sterol binding by OSBP-related protein 1L regulates late endosome motility and functionTerhi Vihervaara, Riikka-Liisa Uronen, Gerd Wohlfahrt, et al.
Chemistry and Physics of Lipids|March 23, 2011
Cytoplasmic oxysterol-binding proteins: sterol sensors or transporters?Terhi Vihervaara, Maurice Jansen, Riikka-Liisa Uronen, et al.
Scandinavian Journal of Gastroenterology|February 11, 2025
The use of ELF in predicting liver fibrosis prevalence and fibrosis progression in the general populationKustaa Saarinen, Martti Färkkilä, Antti Jula, et al.
JHEP Reports : Innovation in Hepatology|June 19, 2023
Enhanced liver Fibrosis® test predicts liver-related outcomes in the general populationKustaa Saarinen, Martti Färkkilä, Antti Jula, et al.
JHEP Reports : Innovation in Hepatology|October 18, 2023
Erratum to: "Enhanced Liver Fibrosis® test predicts liver-related outcomes in the general population" (JHEP Reports 2023; 5: 100765)Kustaa Saarinen, Martti Färkkilä, Antti Jula, et al.
Pageof 5